Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Richard B. Jones

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentBen May Department
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stark AL, Madian AG, Williams SW, Chen V, Wing C, Hause RJ, To LA, Gill AL, Myers JL, Gorsic LK, Ciaccio MF, White KP, Jones RB, Dolan ME. Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination Therapy. J Proteome Res. 2017 11 03; 16(11):4227-4236. PMID: 28902521.
      View in: PubMed
    2. Ciaccio MF, Jones RB. Microwestern Arrays for Systems-Level Analysis of SH2 Domain-Containing Proteins. Methods Mol Biol. 2017; 1555:453-473. PMID: 28092050.
      View in: PubMed
    3. Ciaccio MF, Chen VC, Jones RB, Bagheri N. The DIONESUS algorithm provides scalable and accurate reconstruction of dynamic phosphoproteomic networks to reveal new drug targets. Integr Biol (Camb). 2015 Jul; 7(7):776-91. PMID: 26057728.
      View in: PubMed
    4. Hause RJ, Stark AL, Antao NN, Gorsic LK, Chung SH, Brown CD, Wong SS, Gill DF, Myers JL, To LA, White KP, Dolan ME, Jones RB. Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels. Am J Hum Genet. 2014 Aug 07; 95(2):194-208. PMID: 25087611.
      View in: PubMed
    5. Leung KK, Hause RJ, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Mol Cell Proteomics. 2014 Jul; 13(7):1705-23. PMID: 24728074.
      View in: PubMed
    6. Stark AL, Hause RJ, Gorsic LK, Antao NN, Wong SS, Chung SH, Gill DF, Im HK, Myers JL, White KP, Jones RB, Dolan ME. Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy. PLoS Genet. 2014 Apr; 10(4):e1004192. PMID: 24699359.
      View in: PubMed
    7. Jones RB. Do low-affinity ErbB receptor protein interactions represent the base of a cell signaling iceberg? Expert Rev Proteomics. 2013 Apr; 10(2):115-8. PMID: 23573776.
      View in: PubMed
    8. Hause RJ, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. PLoS One. 2012; 7(9):e44471. PMID: 22973453.
      View in: PubMed
    9. Madian AG, Wheeler HE, Jones RB, Dolan ME. Relating human genetic variation to variation in drug responses. Trends Genet. 2012 Oct; 28(10):487-95. PMID: 22840197.
      View in: PubMed
    10. Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prev Res (Phila). 2012 May; 5(5):788-97. PMID: 22562408.
      View in: PubMed
    11. Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, Ciaccio MF, Gat-Viks I, Tonti E, DeGrace MM, Clauser KR, Garber M, Eisenhaure TM, Yosef N, Robinson J, Sutton A, Andersen MS, Root DE, von Andrian U, Jones RB, Park H, Carr SA, Regev A, Amit I, Hacohen N. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell. 2011 Nov 11; 147(4):853-67. PMID: 22078882.
      View in: PubMed
    12. Hause RJ, Kim HD, Leung KK, Jones RB. Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches. Expert Rev Proteomics. 2011 Oct; 8(5):565-75. PMID: 21999828.
      View in: PubMed
    13. Liu J, Kuo WL, Seiwert TY, Lingen M, Ciaccio MF, Jones RB, Rosner MR, Cohen EE. Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head Neck. 2011 Dec; 33(12):1774-82. PMID: 21438065.
      View in: PubMed
    14. Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB, Nash PD. SH2 domains recognize contextual peptide sequence information to determine selectivity. Mol Cell Proteomics. 2010 Nov; 9(11):2391-404. PMID: 20627867.
      View in: PubMed
    15. Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol. 2010 Apr; 17(4):519-27. PMID: 20357770.
      View in: PubMed
    16. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods. 2010 Feb; 7(2):148-55. PMID: 20101245.
      View in: PubMed
    17. Netzer N, Goodenbour JM, David A, Dittmar KA, Jones RB, Schneider JR, Boone D, Eves EM, Rosner MR, Gibbs JS, Embry A, Dolan B, Das S, Hickman HD, Berglund P, Bennink JR, Yewdell JW, Pan T. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 2009 Nov 26; 462(7272):522-6. PMID: 19940929.
      View in: PubMed
    18. Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Mol Cancer Res. 2008 Jun; 6(6):885-91. PMID: 18567793.
      View in: PubMed
    19. Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12; 439(7073):168-74. PMID: 16273093.
      View in: PubMed
    20. Luo Y, Cho HH, Jones RB, Jin C, McKeehan WL. Improved production of recombinant fibroblast growth factor 7 (FGF7/KGF) from bacteria in high magnesium chloride. Protein Expr Purif. 2004 Feb; 33(2):326-31. PMID: 14711521.
      View in: PubMed
    21. Wade MJ, Johnson NA, Jones R, Siguel V, McNaughton M. Genetic variation segregating in natural populations of Tribolium castaneum affecting traits observed in hybrids with T. freemani. Genetics. 1997 Nov; 147(3):1235-47. PMID: 9383066.
      View in: PubMed
    22. Jones R, Haselkorn R. The DNA sequence of the Rhodobacter capsulatus ntrA, ntrB and ntrC gene analogues required for nitrogen fixation. Mol Gen Genet. 1989 Feb; 215(3):507-16. PMID: 2710108.
      View in: PubMed
    23. Jones R, Haselkorn R. The DNA sequence of the Rhodobacter capsulatus nifH gene. Nucleic Acids Res. 1988 Sep 12; 16(17):8735. PMID: 3419937.
      View in: PubMed
    24. Lin A, Chan YL, Jones R, Wool IG. The primary structure of rat ribosomal protein S12. The relationship of rat S12 to other ribosomal proteins and a correlation of the amino acid sequences of rat and yeast ribosomal proteins. J Biol Chem. 1987 Oct 15; 262(29):14343-51. PMID: 3308890.
      View in: PubMed
    25. Pullman TN, Eichelberger L, Alving AS, Jones R, Craige B, Whorton CM. THE USE OF SN-10,275 IN THE PROPHYLAXIS AND TREATMENT OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May; 27(3 Pt 2):12-6. PMID: 16695623.
      View in: PubMed
    26. Craige B, Whorton CM, Jones R, Pullman TN, Alving AS, Eichelberger L, Rothman S. A LICHEN-PLANUS-LIKE ERUPTION OCCURRING DURING THE COURSE OF CHLOROQUINE ADMINISTRATION. J Clin Invest. 1948 May; 27(3 Pt 2):56-9. PMID: 16695635.
      View in: PubMed
    27. Alving AS, Craige B, Pullman TN, Whorton CM, Jones R, Eichelberger L. PROCEDURES USED AT STATEVILLE PENITENTIARY FOR THE TESTING OF POTENTIAL ANTIMALARIAL AGENTS. J Clin Invest. 1948 May; 27(3 Pt 2):2-5. PMID: 16695630.
      View in: PubMed
    28. Craige B, Eichelberger L, Jones R, Alving AS, Pullman TN, Whorton CM. THE TOXICITY OF LARGE DOSES OF PENTAQUINE (SN-13,276), A NEW ANTIMALARIAL DRUG. J Clin Invest. 1948 May; 27(3 Pt 2):17-24. PMID: 16695629.
      View in: PubMed
    29. Jones R, Craige B, Alving AS, Whorton CM, Pullman TN, Eichelberger L. A STUDY OF THE PROPHYLACTIC EFFECTIVENESS OF SEVERAL 8-AMINOQUINOLINES IN SPOROZOITE-INDUCED VIVAX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May; 27(3 Pt 2):6-11. PMID: 16695636.
      View in: PubMed
    30. Jones R, Pullman TN, Whorton CM, Craige B, Alving AS, Eichelberger L. THE THERAPEUTIC EFFECTIVENESS OF LARGE DOSES OF PALUDRINE IN ACUTE ATTACKS OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May; 27(3 Pt 2):51-5. PMID: 16695634.
      View in: PubMed
    31. Alving AS, Craige B, Jones R, Whorton CM, Pullman TN, Eichelberger L. PENTAQUINE (SN-13,276), A THERAPEUTIC AGENT EFFECTIVE IN REDUCING THE RELAPSE RATE IN VIV AX MALARIA. J Clin Invest. 1948 May; 27(3 Pt 2):25-33. PMID: 16695631.
      View in: PubMed
    32. Pullman TN, Craige B, Alving AS, Whorton CM, Jones R, Eichelberger L. COMPARISON OF CHLOROQUINE, QUINACRINE (ATABRINE), AND QUININE IN THE TREATMENT OF ACUTE ATTACKS OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May; 27(3 Pt 2):46-50. PMID: 16695633.
      View in: PubMed
    33. Alving AS, Eichelberger L, Craige B, Jones R, Whorton CM, Pullman TN. STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618). J Clin Invest. 1948 May; 27(3 Pt 2):60-5. PMID: 16695637.
      View in: PubMed
    34. Alving AS, Pullman TN, Craige B, Jones R, Whorton CM, Eichelberger L. THE CLINICAL TRIAL OF EIGHTEEN ANALOGUES OF PAMAQUIN (PLASMOCHIN) IN VIV AX MALARIA (CHESSON STRAIN). J Clin Invest. 1948 May; 27(3 Pt 2):34-45. PMID: 16695632.
      View in: PubMed
    Jones's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _